NCT05660356View on ClinicalTrials.gov

Growth Hormone Deficiency in Mild Traumatic Brain Injury

EARLY_PHASE1UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

February 29, 2024

Study Completion Date

February 28, 2025

Conditions
Growth Hormone TreatmentGrowth Hormone DeficiencyConcussion, MildConcussion Post Syndrome
Interventions
DRUG

Growth Hormone

Pfizer provided GH therapy

DRUG

Placebo

Pfizer provided placebo

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of Calgary

OTHER

NCT05660356 - Growth Hormone Deficiency in Mild Traumatic Brain Injury | Biotech Hunter | Biotech Hunter